Adverse drug events in hospitalized patients: Excess length of stay, extra costs, and attributable mortality

Journal of the American Medical Association

Volumn 277, Issue 4, 1997, Pages 301-306

  Classen, David C ^a   Pestotnik, Stanley L ^a   Evans, R Scott ^a   Lloyd, James F ^a   Burke, John P ^a  

^a LDS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; DIGOXIN; IMIPENEM; MORPHINE DERIVATIVE; OXYCODONE; PETHIDINE; VANCOMYCIN; WARFARIN;

ADULT; ARTICLE; CASE CONTROL STUDY; CONFUSION; CONTROLLED STUDY; DRUG FATALITY; DRUG INDUCED DISEASE; FEMALE; FEVER; HEART ARRHYTHMIA; HOSPITAL COST; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; PRIORITY JOURNAL; PRURITUS; RASH; RISK ASSESSMENT; VERTIGO; VOMITING;

EID: 0031032055     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.4.301     Document Type: Article

References (40)

1. Johnsort JA, Bootman JL. Drug-related morbidity and mortality: a cost of illness model. Arch Intern Med. 1995;155:1949-1956.
2. Talley RB, Laventurier MF. Drag-induced illness. JAMA. 1974;229:1043-1048.
3. Porter J, Jick H. Drug-related deaths among medical inpatients. JAMA. 1977;237:879-881.
4. Jick H. Drugs - remarkably non-toxic. N Engl J Med. 1974;219:824-828.
5. Caranasos GJ, Stewart RB, Cluff LE. Drug-induced illness leading to hospitalizatian. JAMA. 1974;228:713-717.
6. Miller RR. Hospital admissions due to adverse drug reactions: a report from the Boston Collaborative Drug Surveillance Program. Arch Intern Med. 1974;134:219-223.
7. Melmon KL. Preventable drug reactions: causes and cures. N Engl J Med. 1971;284:1361-1368.
8. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975;234:1236-1241.
9. Cluff LE, Caranasos GJ, Stewart RB. Clinical problems with drugs. In:Smith LH, ed. Major Problems in Internal Medicine. Philadelphia, Pa: WB Saunders Co; 1975:vol 5.
10. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study. N Engl J Med. 1991;324:377-384.
11. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-2851.
12. Kuperman G, Gardner RM, Pryor TA. The HELP System: A Dynamic Hospital Information System. New York, NY: Springer Verlag; 1990.
13. Evans RS, Larsen RA, Burke JP, et al. Computer surveillance of hospital-acquired infections and antibiotic use. JAMA. 1986;256:1007-1011.
14. Classen DC, Pestotnik SL, Evans RS, Burke JP. Description of a computerized adverse drug event monitor using a hospital information system. Hasp Pharm. 1992;27:774, 776-779, 783.
15. Evans RS, Classen DC, Stevens LE, et al. Using a hospital information system to assess the effects of adverse drug events.In: Safran C, ed. Proceedings From the Seventeenth Annual Symposium on Computer Applications in Medical Care. New York, NY: McGraw-Hill Inc; 1993:161-165.
16. Classen DC. Assessing the Impact of Adverse Hospital Events on the Cost of Hospitalization and Other Patient Outcomes. Salt Lake City: University of Utah; 1993. Thesis.
17. The LDS Hospital nurse acuity system. In: Nursing Care Manual. Salt Lake City, Utah: LDS Hospital; 1990.
18. Davis RB, Iezzoni LI, Phillips RS, et al. Predicting in-hospital mortality: the importance of functional status information. Med Care. 1995;33:906-921.
19. Van Ruiswyk J, Hartz A., Guse C, Sigmann P, Porth C, Buck K. Nursing assessments: patient severity of illness. Nurs Manag. 1990;23:44-48.
20. Whalen KL. Level of nursing care required by the unstable angina patient. Crit Care Med. 1990; 18:505-508.
21. Lovett RB, Wagner L, McMillan S. Validity and reliability of a pediatric hematology oncology patient acuity tool. J Pediatr Oncol Nurs. 1991;8: 122-130.
22. Meyer D. GRASP: A Patient Information and Workload Management System. Morgantown, NC: MCS; 1978.
23. Standard Cost Manager: User's Guide. Cleveland, Ohio: Ernst and Whinney, Intermountain Health Care Inc; 1987.
24. Haley RW. Measuring the cost of nosocomial infections: methods for estimating the economic burden on the hospital. Am J Med. 1991;91:32S-38S.
25. Haley RW. Cost benefit analysis of infection control programs. In: Bennett JV, Brachman PS, eds. Hospital Infections. 3rd ed. Boston, Mass: Little Brown & Co; 1992:507-532.
26. Polissar L, Diehr P. Regression analysis in health services research: the use of dummy variables. Med Care. 1982;20:959-966.
27. Bates DW, Cullen DJ, Laird N, et al, for the ADE Prevention Study Group. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
28. Chrischilles EA, Segar ET, Wallace RB. Self-reported adverse drug reactions and related resource use. Ann Intern Med. 1992;117:634-640.
29. Schneider PJ, Gift MG, Lee YP, Rothermich EA, Sill BE. Cost of medication related problems at a university hospital. Am J Health Syst Pharm. 1995;52:2415-2418.
30. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-527.
31. Colley CA, Lucas LM. Polypharmacy: the cure becomes the disease. J Gen Intern Med. 1993;8: 278-283.
32. Berwick DM. Eleven worthy aims for clinical leadership of health system reform. JAMA. 1994; 272:797-802.
33. Knox RA, Mooney BC. Hospital dosage mistakes not rare: past cases reveal medieation errors. Boston Globe. April 16, 1995:1.
34. Prince BS, Goetz CM, Rihn TL, Olsky M. Drug-related emergency department visits and hospital admissions. Am J Hosp Pharm. 1992;49:1696-1700.
35. Bloom BS. Direct medical costs of disease and gastrointestinal side effects during treatment for arthritis. Am J Med. 1988;84:20-24.
36. Sloan FA, Gordon GS, Cocks DL. Hospital drug formularies and the use of hospital services. Med Care. 1993;31:851-867.
37. Evans RS, Pestotnik SL, Classen DC, Bass SB, Burke JP. Prevention of adverse drug events through computerized surveillance. In: Frisse ME, ed. Proceedings From the Sixteenth Annual Symposium on Computer Applications in Medical Care. New York, NY: McGraw-Hill Inc; 1992:437-441.
38. Pestotnik SL, Classen DC, Evans RS, Stevens LE, Burke JP. Prospective surveillance ofimipenem/ cilastatin use and associated seizures using a hospital information system. Ann Pharmacother. 1993; 27:497-501.
39. Evans RS, Classen DC, Pestotnik SL, Clemmer TP, Weaver LK, Burke JP. A decision support tool for antibiotic therapy. In: Gardner RM, ed. Proceedings From the Nineteenth Annual Symposium on Computer Applications in Medical Care. Philadelphia, Pa: Hanley & Belfus; 1995:651-655.
40. Powe NR, Griffiths RI. The clinical-economic trial: promise, problems, and challenges. Control Clin Trials. 1995;16:377-394.